Skip to content

Press Releases

Date Title
29-Oct-2020 Illumina Reports Financial Results for Third Quarter of Fiscal Year 2020
28-Sep-2020 Illumina to Announce Third Quarter 2020 Financial Results on Thursday, October 29, 2020
23-Sep-2020 Illumina to Webcast Upcoming Investor Conference Presentation
21-Sep-2020 Illumina to Acquire GRAIL to Launch New Era of Cancer Detection
14-Sep-2020 Genomic Leaders Collaborate to Create Australia’s First National COVID-19 Tracking System
25-Aug-2020 Illumina Welcomes Kathryne Reeves as Chief Marketing Officer
07-Aug-2020 Illumina to Webcast Upcoming Investor Conference Presentation
06-Aug-2020 Illumina Announces the NovaSeqTM 6000 v1.5 Reagent Kit Unlocking Deeper Discoveries with the $600 Genome
06-Aug-2020 Illumina Reports Financial Results for Second Quarter of Fiscal Year 2020
16-Jul-2020 Illumina to Announce Second Quarter 2020 Financial Results on Thursday, August 6, 2020
08-Jul-2020 Illumina Launches TruSight Software Suite to Accelerate the Identification of Genetic Diseases
23-Jun-2020 Illumina Accelerator Welcomes First Global Cohort of Genomics Startups
17-Jun-2020 Illumina Acquires BlueBee to Accelerate Processing, Analysis and Sharing of Next Generation Sequencing Data at Scale
16-Jun-2020 Illumina Inc. Announces that U.S. Federal Court Issues Preliminary Injunction Against BGI Companies
09-Jun-2020 Illumina Receives First FDA Emergency Use Authorization for a Sequencing-Based COVID-19 Diagnostic Test
18-May-2020 Illumina, Inc. and the Illumina Corporate Foundation Commit $10 Million to COVID-19 Response and Research
04-May-2020 Illumina Welcomes Alex Aravanis as Chief Technology Officer and Appoints Mostafa Ronaghi to Lead Entrepreneurial Development
30-Apr-2020 Illumina Reports Financial Results for First Quarter of Fiscal Year 2020
28-Apr-2020 Illumina’s Donation to the Africa Centre for Disease Control and Prevention Expands their Capability for Sequencing-Based COVID-19 Surveillance
16-Apr-2020 Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19
14-Apr-2020 Illumina Reports Preliminary Revenue for First Quarter of Fiscal Year 2020
27-Feb-2020 Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.
12-Feb-2020 Illumina to Webcast Upcoming Investor Conference Presentations
06-Feb-2020 Dr. Scott Gottlieb, former US FDA Commissioner, joins Illumina’s Board of Directors
29-Jan-2020 Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019
13-Jan-2020 Illumina to Announce Fourth Quarter and Fiscal Year 2019 Financial Results on Wednesday, January 29, 2020
13-Jan-2020 Illumina Announces New Sequencing System, Partnership with Roche and Software Suite to Accelerate Adoption of Genomics
13-Jan-2020 Illumina and Roche Partner to Broaden Patient Access to Genomic Testing
10-Jan-2020 Illumina Files Patent Infringement Suits Against BGI in Sweden and the United Kingdom
02-Jan-2020 Illumina and Pacific Biosciences Announce Termination of Merger Agreement